BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 16, 2009
View Archived Issues
Alnylam presents report on objectives for 2009
Read More
Jennerex treats first patients in phase II JX-594 trial for liver cancer
Read More
AcelRx reports positive results from NanoTab trial in pain and anxiety
Read More
EVP-6124 shows improvement in cognition biomarkers in schizophrenia
Read More
Human Genome Sciences provides pipeline update
Read More
Vertex updates 2009 clinical development programs in hepatitis C and cystic fibrosis
Read More
Algeta completes phase II clinical program for Alpharadin
Read More
Cephalon signs option agreement to acquire Ception
Read More
Jazz completes enrollment in phase III clinical trial of JZP-6 for fibromyalgia
Read More
FDA advisory committee to discuss Dyax's BLA for DX-88 in HAE
Read More
InNexus Biotechnology's anticancer candidate DXL-625 safe and effective in primate study
Read More
Sygnis presents update on preparations for phase II efficacy trial of AX-200 in acute stroke
Read More
Akela achieves milestone payment from Janssen related to phase III study of Taifun
Read More
FDA issues complete response letter for Schering-Plough's NDA for Saphris
Read More
Savella approved by the FDA for the management of fibromyalgia
Read More
Studies point to SRC as a therapeutic target in glioblastoma - and the possible use of dasatinib
Read More
Repigmentation of vitiligo seen with tacrolimus 0.1% cream
Read More
Amicus Therapeutics presents progress of three lead clinical programs
Read More
Kyowa Hakko Kirin to further evaluate KW-6002 in Japan
Read More
Cell Therapeutics reports target 2009 milestones
Read More
Roche divulges new GPCR-targeting antibodies for diabetes and neurological disorders
Read More
Schering-Plough scientists claim new KSP inhibitors with anticancer properties in recent patent
Read More
Novel anticancer PI3Kalpha inhibitors developed at GSK
Read More
New York University discloses new antimicrobial triazine compounds
Read More
New non-nucleoside reverse transcriptase inhibitors prepared and tested at GSK
Read More